Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT04052204
Previous Study | Return to List | Next Study

Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04052204
Recruitment Status : Terminated (The recruitment of new subjects has been stopped with no intention of restarting the study before reaching the protocol specified End of Trial.)
First Posted : August 9, 2019
Last Update Posted : January 13, 2021
Sponsor:
Collaborators:
EMD Serono
Nektar Therapeutics
Astellas Pharma Inc
Information provided by (Responsible Party):
Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : September 29, 2020
Actual Study Completion Date : September 29, 2020